期刊
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
卷 19, 期 4, 页码 540-546出版社
BMJ PUBLISHING GROUP
DOI: 10.1111/IGC.0b013e3181a44bc8
关键词
Periodate-oxidized; borohydride-reduced heparin (RO-heparin); L-selectin; Heparan sulfate-like proteoglycans; Neutrophils; Metastasis
资金
- Program for Youth Academic Backbone in Heilongjiang Provincial University [1152GO49]
- Heilongjiang Province Science Foundation for Youths [QC07C108]
Accumulating evidence indicates that hematogenous metastasis is facilitated by tumor cell-leukocyte emboli formation, and L-selectin plays a major role in the process. Several independent studies have indicated that tumor metastasis can be inhibited by chemically modified heparin with low anticoagulant activity in the different tumor models. In the present study, we demonstrated that chemically modified nonanticoagulation heparin derivate (periodate-oxidized, borohydride-reduced heparin [RO-heparin]) can inhibit the binding of L-selectin to HO-8910 cells, block the adhering of HO-8910 to Chinese hamster ovary cells expressing a transfected human L-selectin complementary DNA, and affect the interactions of neutrophils with HO-8910 cells. Flow cytometric analysis with the heparan sulfate-specific monoclonal antibody revealed that HO-8910 cells express heparan sulfate-like proteoglycans. Furthermore, heparinase treatment impaired L-selectin binding, indicating that heparan sulfate-like proteoglycans on the tumor cell surface are implicated in the binding of L-selectin to HO-8910 cells. These findings suggest that RO-heparin with low anticoagulant activities may have potential value as therapeutic agents that block L-selectin-mediated cell adhesion and prevent tumor metastasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据